>> ILE is one of the biotech companies I used to consider a quasi-legit scam, but they brought in Nick Teti, the former CEO of Inamed, a top cosmeceuticals company that was acquired by Allergan. Teti seems to have made a difference, and I give ILE credit for securing an SPA for these high-risk pivotal trials. <<
>> For a variety of reasons, Isolagen has had a few tough years, and shareholders of the company have suffered… However, in June 2006 the company brought in Nicholas L. Teti to turnaround the company. Mr. Teti was the former CEO of Inamed Corp., a healthcare company that developed aesthetic products, and was sold to Allergan for $3.2 billion in 2005… It appears to us that the main problem for ILE in the past, had been that it did not have the right people in place with the proper experience in FDA Protocol Design... The arrival of Mr. Teti and his team of proven executives, however, greatly increases the odds that Isolagen shareholders will finally see substantial returns… <<
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.